2018 American Transplant Congress

June 2-6, 2018 in Seattle, WA

View by Title View Sessions

View by Date

Jump to: View All • a b c d e f g h i j k [l] m n o p q r s t u v w x y z

Lab Turnaround Times: A Performance Improvement Project in Post Kidney/Pancreas Transplant Clinic

M. Farrell, S. Kapadia.
Lack of Efficacy of Eculizumab for Prevention of Delayed Graft Function (DGF) in Deceased Donor Kidney Transplant Recipients

P. Heeger,¹ E. Akalin,² M. Baweja,¹ R. Bloom,³ S. Florman,¹ B. Haydel,¹ D. Hricik,⁴ S. Kulkarni,⁵ A. Mehrotra,¹ A. Patel,⁶ E. Poggio,⁷ L. Ratner,⁸ S. Schröppel,¹ R. Shapiro.¹
Lactate/platelet Ratio after Liver Transplantation; a Novel Predictor for Short-Term Graft Failure

K. Takahashi,¹ S. Nagai,² M. Safwan,² K. Collins,² M. Rizzari,² A. Yoshida,² N. Ohkohchi,¹ M. Abouljoud.²
LAG-3 Deletion Upregulates Memory in a Dendritic Cell-Dependent Process

S. Gibney,¹ M. Efre,¹ T. Ashry,¹ C. Yang,¹ T. O'Shea,^1,2 R. White,² P. Russell,¹ J. Madsen,¹ R. Colvin,² A. Alessandrini.^1,2
Landscape of Living Donor Kidney Transplantation with International Donors in the United States

A. Thomas,¹ M. Henderson,¹ A. Shaffer,¹ A. Massie,¹ B. Koons,² K. Lentine,³ D. Segev,¹ F. Al Ammary.¹
Laparoscopic Donor Nephrectomy – The BMI Effect

V. Chia,¹ F. Khan,² M. Newell,² L. J. Chen.³
Laparoscopic Donor Nephrectomy Safety: Experience of 500 Cases in Hispanic Population at a Single Institution

Y. Baez Suarez, F. Giron Luque, J. Amaya Nieto.
Large Decrease in Liver Waiting List Dropout Rate for MELD > 14

D. Schladt,¹ J. Pyke,¹ A. Israni,¹ W. Kim,² J. Lake,³ J. Snyder.¹
Large Volume Intraoperative Fluid Use in Small (<20kg) Renal Recipients is Safe

N. Liow,¹ N. Mudalige,² N. Melhem,¹ S. Boyle,¹ N. Kessaris,¹ H. Hume-Smith,¹ S. Marks,¹ N. Mamode,¹ J. Stojanovic.¹
Late Conversion from Calcineurin Inhibitors to Belatacept is Associated with a Sustained Improvement in Kidney Allograft Function

S. Sethi, J. Choi, A. Vo, R. Najjar, A. Peng, S. Jordan, E. Huang.
Late Donor-Specific Antibody (Especially Class II) Development is Associated with an Increased Risk for Cardiac Allograft Vasculopathy

E. Kransdorf, J. Patel, M. Kittleson, R. Levine, S. Dimbil, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
Latent Tuberculosis Diagnosis Prior to Kidney Transplantation in a High Burden Country: Improvement with Serological Tests

V. Garcia, G. Meinerz, C. da Silva, E. Keitel.
LDLT for High MELD Recipients: A Single Center Experience

S. Ganesh, M. Molinari, T. Amit, H. Christopher, H. Abhinav.
Left Ventricular Assist Devices Complicated by Gastrointestinal Bleeding and Outcomes on Transplant

L. Aurora, O. Sadiq, H. Nemeh, C. Williams.
Legal Status, Criminal History, and Substance Use in Listing Decisions

G. Lee, A. Wall, J. Maldonado, D. Magnus.
Less Induction Therapy Means Fewer Early Readmissions with No Change in Rejection or Infection

S. Kush, K. Boyle, J. Gray, S. Rega, I. Feurer, A. Shah, J. Lindenfeld.
Leukocytes from Recipients with Severe Primary Graft Dysfunction after Lung Transplant Adoptively Transfer Alloreactivity to Vessel Grafts Trans Vivo

A-.K. Knoefel,¹ T. Siemeni,¹ N. Madrahimov,¹ W. Sommer,¹ M. Avsar,¹ L. Ahrens,¹ I. Tudorache,¹ A. Haverich,¹ C. Falk,² G. Warnecke.¹
Linking Donor Ischemia Reperfusion Injury (IRI) to Costimulatory Blockade Resistant Murine Heart Graft Rejection through Complement-Initiated Necroptosis

R. Ang, N. Chun, A. Ting, P. Heeger.
Liposomal Bupivacaine: Friend or Foe in Kidney Donation?

Y. Yang, A. Jantz, B. Summers, A. Patel, L. Malinzak, N. Sulejmani.
Liver Allocation: One OPO's Experience with Expedited versus Non-Expedited Placement

C. Muse, R. Squires, C. Trahan, J. Whaley, J. Orlowski.
Liver Biopsy Fibrosis Not Liver Imaging Predicts Survival after Heart Transplant

J. Patel, M. Kittleson, E. Kransdorf, R. Levine, S. Dimbil, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
Liver Preservation with Machine Perfusion and a New Human-Derived Hemoglobin-Based Oxygen Carrier Solution (HDHBOC)

W. R. Light,¹ A. Malavalli,¹ K. Vandegriff,¹ P. Fontes.²
Liver Retransplantation and Renal Failure: The Benefit of Simultaneous Kidney Transplant

J. Berumen,¹ V. Irine,² S. Mita,² S. Gabriel,¹ M. Kristin.¹
Liver Stiffness Measurement, but Not Controlled Attenuation Parameter, is Increased in Deceased Liver Donors at the Time of Transplant Procurement

A. Duarte-Rojo,¹ G. Barone,¹ D. Borja-Cacho,¹ W. Concepcion,² M. Shaheen,³ J. Heimbach,³ W. Kim.²
Liver Transplant Patients with MELD>50 at Listing Have Poor Waitlist Outcomes and Similar Post Transplant Survival to Status 1A Patients

M. Safwan, R. Schilke, U. Nwagu, K. Collins, M. Rizzari, A. Yoshida, M. Abouljoud, S. Nagai.
Liver Transplant Recipients with End-Stage Renal Disease Largely Benefit from Kidney Transplantation

W. Ju, Y. Tang, Q. Zhao, L. Jing, S. Huang, Z. Zhu, F. Ji, Z. Zhang, X. He, G. Chen, Z. Guo, D. Wang.
Liver Transplant Survival Index for Recipients with High MELD Score: A Model for Post-Transplant Survival in Severely Ill Patients

J. Steggerda,¹ M. Bloom,¹ C. Bresee,² D. Malinoski,³ A. Klein,¹ K. Kim.¹
Liver Transplantation as a Life Saving Procedure after Post Resection Liver Failure and Iatrogenic Liver Injuries

T. Thorsen,¹ J. Solheim,¹ R. Horneland,¹ P-.D. Line,¹ K. Labori,² E. Aandahl.¹
Liver Transplantation for Hepatocellular Carcinoma Outperform Other Populations in the New Hepatitis C Era

A. Alsina,¹ A. Athienitis,² J. Buggs,¹ E. Fallon,³ E. Parkinson,³ C. Albers,³ N. Kemmer.³
Liver Transplantation for Locally Advanced Intrahepatic Cholangiocarcinoma Treated with Neoadjuvant Therapy: A Pilot Cohort Study

K. Lunsford,¹ M. Javle,² K. Heyne,¹ R. Shroff,² R. Hassan Ali,² C. Mobley,¹ D. Victor,¹ A. Kaseb,² T. Aloia,² C. Conrad,² X. Li,¹ H. Monsour,¹ A. Gaber,¹ J-.N. Vauthey,² R. Ghobrial.¹
Liver Transplantation for Patients with Hepatocellular Carcinoma Presenting beyond Milan Criteria: Analysis of 789 Patients from the US Multicenter HCC Transplant Consortium

V. Agopian, United States Multicenter HCC Transplant Consortium.
Liver Transplantation for Severe Alcoholic Hepatitis: Is Early Always Necessary?

T. Wu,¹ N. Nissen,² C. Galloway,² A. Klein,² T. Tran,¹ W. Ayoub,¹ M. Noureddin,¹ I. Kim,² T. Todo,² V. Sundaram.¹
Liver Transplantation in Foreign Nationals: Lower Rates of Waitlist Mortality and Higher Rates of Lost to Follow-Up Post-Transplant

N. Ferrante, D. Goldberg.
Liver Transplantation in Patients with Spontaneous Spleno-Renal Shunt

M. Gastaca,¹ M. Bruno,² P. Ruiz,¹ A. Ventoso,¹ I. Palomares,¹ M. Prieto,¹ A. Valdivieso.¹
Liver Transplantation Outcomes after Share 35: Analysis of NASH Recipients from UNOS Database

Y. Zhang,¹ M. Boktour.²
Liver Transplantation Post Gastric Bypass: Surgical Complications and Outcomes

A. Vijay, A. Nigam, R. Girlanda, A. Kroemer, J. Hawksworth, C. Matsumoto, T. Fishbein.
Liver Transplantation Using Pediatric versus Adult Donor Grafts in Adult Recipients

Y. Tang, Q. Zhao, Z. Zhang, L. Wang, W. Ju, Z. Zhu, S. Huang, Z. Guo, X. He, G. Chen.
Liver Transplantation with or without Left Renal Vein Ligation: Comparative Study of 105 Cases

M. Perosa,¹ H. Noujaim,¹ J. Branez,¹ L. Mota,¹ B. Zeballos,¹ R. Santos,¹ A. Watanabe,² G. Ferreira,² A. Moraes,² A. Silvestre,³ G. Martinho,⁴ N. Siqueira,⁵ T. Genzini.¹
Liver Transplants from Older Donors Have Worse Outcomes in Elderly Recipients with Renal Dysfunction

R. Schilke,¹ M. Safwan,¹ S. Nagai,¹ M. Abouljoud,² A. Patel.¹
Livers from Diabetic Donors Can Safely Be Used in Donation after Circulatory Death Liver Transplantation

I. Brüggenwirth,¹ I. Vasiliauskaire,² A. Westerkamp,¹ W. Polak,² A. Braat,³ R. Porte.¹
Livers from Donation after Circulatory Death Donors Can Be Safely Used for Retransplantation

O. van Leeuwen,¹ M. van Reeven,² J. Erdmann,³ H. Metselaar,⁴ A. van den Berg,⁵ B. van Hoek,⁶ W. Polak,² R. Porte.¹
Living Donor Liver Transplant (LDLT) at a Single Center- Intraoperative Technical Modifications and Optimization of Flow Dynamics to Improve Outcomes

A. Humar, S. Ganesh, A. Tevar, M. Molinari, C. Hughes.
Living Donor Liver Transplantation for Alcoholic Liver Disease: Data from the A2ALL Study

H. Braun, J. Dodge, J. Grab, S. Syed, G. Roll, C. Freise, J. Roberts, N. Ascher.
Living Donor Liver Transplantation for Hepatocellular Carcinoma beyond UCSF Criteria: Can We Achieve a Modest Long-Term Survival? A Single Center Retrospective Analysis of Using Extended Criteria

A. Thorat, L.-B. Jeng, S.-C. Hsu, C.-C. Yeh, T.-H. Chen, H.-R. Yang, K.-S. Poon, P.-C. Li.
Living Donor Nephrectomy: Is It as Safe as It Can Be? Analysis of Living Donor Deaths in the United States

D. Keith,¹ J. Brown,² K. Andreoni.³
Living Donor Renal Transplantation in Adult Renal Transplant Recipients Varies Markedly across UNOS Networks

A. Brar,¹ A. Gruessner,¹ M. Salifu,¹ R. Gruessner,² N. Sumrani,² D. John,² F. Tedla.¹
Living Kidney Donation: Impact of Transplant Center Labor, Organization, and Resources

D. Moore,¹ M. Dietrich,¹ P. Buerhaus,² J. Rodrigue,³ A. Minnick.¹
Living Liver Donation is Safe in Donors Heterozygous for an alpha-1 Antitrypsin Gene Mutation

T. Bittermann,¹ L. Wood,² P. Abt,² A. Shaked,² K. Olthoff,² D. Goldberg.^1,3
Living Liver Donation: The Role of Facebook in Directed Donation

A. Lai, J. Steel, S. Ganesh, O. Ola, S. Shen, N. Zharichenko, S. Nawaz, A. Tevar, A. Humar.
Living Liver Donor Follow-Up: Fewer Than Half of Centers Meet Follow-Up Requirements in the US

A. Thomas, C. Holscher, A. Shaffer, J. Garonzik-Wang, A. Massie, D. Segev, M. Henderson.
Living Liver Donors Face Substantial Out-of-Pocket Donation-Related Costs

J. Ruck, A. Massie, J. Garonzik-Wang, S. Ottman, A. Cameron, B. Philosophe, D. Segev.
Living-Donor Preemptive Kidney Transplant Timing Calculator: An Online Decision Support Tool

M. Barah,¹ M. Kurt,² A. Khojandi,¹ B. Tanriover.³
Locoregional Treatments before Liver Transplantation for Hepatocellular Carcinoma: A Cohort Study from the European Liver Transplant Registry

H-.C. Pommergaard, A. Rostved, R. Adam, L. Thygesen, M. Salizzoni, M. Bravo, D. Cherqui, P. De Simone, K. Boudjema, V. Mazzaferro, O. Soubrane, J. García-Valdecasas, J. Prous, A. Pinna, J. O'Grady, V. Karam, C. Duvoux, A. Rasmussen.
Long Noncoding RNA NEAT1 Induces Tolerogenic Dendritic Cells in Heart Transplantation

J. Wu,^1,2 Y. Zheng,^1,2 S. Li,^1,2 M. Zhang,^1,2 H. Zhang,^1,2 X. Zheng,^1,2 Y. Sun,^1,2 B. Yu.^1,2
Long Term Culture of Functional Bone Marrow-Derived Human Plasma Cells

N. Moore, K. Bonner, M. D'Costa, M. Stegall.
Long Term Histologic Allograft Health is Preserved Despite Rejection during Protocolized Immunosuppression Withdrawal (ISW) in Stable Pediatric Liver Transplant Recipients

V. Venkat,¹ J. Bucuvalas,² M. Martinez,³ K. Spain,⁴ G. Mazariegos,¹ A. Demetris,⁵ S. Feng.⁶
Long Term IVIG Infusions for Treatment of Chronic Antibody Mediated Rejection in Pediatric Kidney Transplant Recipients

A. Al-Uzri,¹ C. Shaut,² S. Iragorri,¹ R. Jenkins,¹ K. Richardson,¹ D. Rozansky,¹ M. Wright,¹ K. Roayaie.²
Long Term Outcomes of a Steroid Free, Low Dose Tacrolimus with Everolimus Regimen in Kidney Transplant

Y. Kassis,¹ S. Park,¹ A. Shetty,¹ J. Leventhal,¹ V. Mas,² L. Gallon.¹
Long Term Outcomes of Renal Allografts with De Novo DSA in the Setting of Stable Graft Function versus Acute Rejection

R. Knight,¹ D. Nguyen,² E. Graviss,² T. Eagar,² S. Kuten,³ S. Patel,³ L. Moore,¹ A. Gaber.¹
Long Term Renal and Patient Risks for Living Kidney Donors

Y. Kim, M. Yu, Y. Kim, H. Lee.
Long-Term Effect of BMI on Renal Function in Asian Living Kidney Donors

J. Na,¹ J. Park,¹ M-.G. Yoon,¹ H. Lee,² Y. Yoon,³ K. Huh,⁴ M. Kim,⁴ S. Kim,⁴ Y. Kim,⁴ W. Han.¹
Long-Term Effects of Ketoconazole in Rapid Tacrolimus Metabolizers Post-Renal Transplantation

J. Ching,¹ S. Anders,¹ M. Janusek,¹ L. Hutchinson,¹ A. Freeman,¹ U. Patel,¹ A. Mohammed,⁴ H. Bohorquez.^2,3
Long-Term Efficacy and Safety of Everolimus Based Immunosuppression on De Novo Kidney Transplantation with 9 Years Follow-Up

S. Narumi,¹ Y. Watarai,¹ N. Goto,² T. Hiramitsu,¹ M. Okada,¹ M. Tsujita,² K. Futamura,² M. Nishihira,³ T. Kobayashi.⁴
Long-Term Efficacy and Safety of Prolonged-Release Tacrolimus in Stable Pediatric Allograft Recipients Converted from Immediate-Release Tacrolimus

N. Undre,¹ J. Rubik,² D. Debray,³ D. Kelly,⁴ F. Iserin,⁵ N. Webb,⁶ P. Czubkowski,² K. Vondrak,⁷ A-.L. Sellier-Leclerc,⁸ S. Riva,⁹ B. Tönshoff,¹⁰ L. D'Antiga,¹¹ S. Marks,¹² R. Reding,¹³ G. Kazeem.¹
Long-Term Follow Up of Living Kidney Donors with CKD at 1 Year after Nephrectomy

J. Na,¹ J. Park,¹ M-.G. Yoon,¹ H. Lee,² Y. Yoon,³ K. Huh,⁴ M. Kim,⁴ S. Kim,⁴ Y. Kim,⁴ W. Han.¹
Long-Term Follow-Up of a Phase 2 Clinical Trial to Induce Tolerance in Living Donor Renal Transplant Recipients

J. Leventhal,¹ J. Galvin,¹ J. Mathew,¹ L. Gallon,¹ D. Stare,¹ K. Kurtenbach,¹ K. Ravindra,³ M. Horwitz,³ J. Miller,¹ M. Abecassis,¹ S. Ildstad.²
Long-Term Follow-Up of Patients with Primary Sclerosing Cholangitis Undergoing Liver Transplantation with Duct-to-Duct Biliary Reconstruction

L. Coromina Hernandez, B. Eghtesad, T. Diago, K. Hashimoto, M. Fujiki, C. Quintini, F. Aucejo, G. Iuppa, A. Hassan, N. Menon, C. Miller.
Long-Term Follow-Up of Pediatric Kidney Recipients Who Received Alemtuzumab Induction

D. Harriman, A. Chen, J. Rogers, R. Stratta, G. Orlando, A. South, J-.J. Lin, A. Farney.
Long-Term HIF-1α Stabilization is Associated with Fibrosis in Rat Lung Allografts

K. Freischlag,¹ B. Ezekian,¹ P. Schroder,¹ J. Everitt,¹ J. Yoon,¹ M. Swiderska-Syn,³ W. Parker,¹ A. Diehl,¹ J. Kwun,¹ S. Knechtle.¹
Long-Term Kidney Transplant Survival after Deceased-Donor Acute Kidney Injury

I. Hall, E. Akalin, J. Bromberg, M. Doshi, M. Harhay, Y. Jia, S. Mansour, S. Mohan, T. Muthumkumar, P. Reese, B. Schröppel, P. Singh, H. Thiessen-Philbrook, F. Weng, C. Parikh.
Long-Term Medical, Financial, Psychosocial, and Overall Health-Related Quality of Life after Living Donation in Liver Transplantation

J. Emamaullee,¹ L. Sher,¹ T-.L. Fong,² K. Dhanireddy,¹ S. Zielsdorf,¹ C. Romero,¹ N. Wade,¹ Y. Genyk.¹
Long-Term Nonhuman Primate Renal Allograft Survival without Ongoing Immunosuppression in Recipients of Delayed Donor Bone Marrow Transplantation

K. Hotta, T. Oura, A. Dehnadi, M. Matsunami, I. Rosales, R. Smith, R. Colvin, A. Cosimi, T. Kawai.
Long-Term Outcome of Kidney Transplant Recipient with HTLV-1 Infection

N. Goto,¹ M. Minami,¹ K. Futamura,² M. Okada,¹ M. Tsujita,¹ T. Hiramitsu,² S. Narumi,² Y. Watarai.²
Long-Term Outcome of Pediatric Kidney Transplantation: A Single-Center Experience over the past Three Decades in Japan

Y. Aoki,¹ H. Satoh,¹ Z. Matsui,¹ R. Hamada,² Y. Hamasaki,³ S. Shishido.³
Long-Term Outcomes after Living Liver Donation: Analysis of National Data Base

S. Hong, N-.J. Yi, K. Yoon, J-.H. Cho, J-.M. Lee, H. Kim, K. Lee, K. Suh.
Long-Term Outcomes and Predictors of Survival after Liver Transplantation for Wilson Disease (WD)

P. Jalal, S. May, A. Rana.
Long-Term Outcomes of a Steroid-Free, Belatacept-Based Immunosuppressive Regimen Plus Sirolimus Using Alentuzumab Induction in Renal Transplantation

A. Guasch,¹ A. Ghali,¹ S. Mead,¹ A. Mehta,¹ H. Xu,² A. Kirk.²
Long-Term Outcomes of Graft Function in Elderly Kidney Transplant Recipients

I. Bajjoka, A. Yaldo, C. Crombez, M. Abouljoud.
Long-Term Outcomes of Liver Transplantation in Patients with Pre-Transplant Renal Dysfunction Treated with Induction Therapy and Delayed Reduced De Novo Once-Daily Tacrolimus

M. Gastaca,¹ J. Bustamante,² A. Ventoso,¹ J. Fernandez,² P. Ruiz,¹ M. Testillano,² M. Prieto,¹ P. Salvador,² I. Palomares,¹ M. Senosiain,² M. Suarez,² A. Valdivieso.¹
Long-Term Outcomes of Primary Kidney Transplant from Expanded Criteria Maastricht Category 3 DCD Donors: A Single-Centre Observational Study

E. Favi,¹ C. Puliatti,² S. Iesari,³ M. Ferraresso,¹ R. Cacciola.²
Long-Term Prognosis of BK Virus Associated Nephropathy in Kidney Transplant Recipients

W. Park,^1,3 S. Yeo,¹ S. Kang,^1,3 H. Park,¹ K. Jin,^1,3 S. Park,^1,3 M. Choe,^2,3 S. Han.^1,3
Long-Term Renal Function in Living Kidney Donors with Renal Cysts

M. Waldram, A. Thomas, A. Muzaale, C. Holscher, A. Nguyen, S. Halpern, S. Anjum, J. Alejo, B. Boyarsky, S. Ottman, J. Garonzik-Wang, D. Segev, A. Massie.
Long-Term Risk of Solid Organ De Novo Malignancies after Liver Transplantation: A French National Study on 11226 Patients

O. Seree, M. Altieri, J. Dumortier, GReF2.
Long-Term Social Outcome after Pediatric Kidney Transplantation

Y. Hamasaki,¹ T. Matsuda,¹ M. Kubota,¹ J. Hashimoto,¹ Y. Takahashi,¹ M. Muramatsu,² T. Kawamura,³ K. Sakai,² S. Shishido.^1,2
Long-Term Success of Treatment for Cardiac Transplant AMR May Depend Upon Suppressing Class II Donor Specific Antibodies

J. Hofmann,¹ D. Weisshaar,² D. Kiprov.³
Longitudinal Analysis of Community Respiratory Virus Infection in Kidney Transplant Recipients

O. Beaird, K. Phonphok, S. Chandrasekaran, O. Garner, S. Bunnapradist, J. Schaenman.
Longitudinal Molecular Assessment of Renal Allograft and Short-Term Outcome: Markers of Injury and Recovery

S. Bontha,¹ A. Fernandez,¹ E. Bardhi,¹ L. Gallon,² V. Mas,¹ D. Maluf.¹
Loss of HIF-1α in CD4 T Cell Improve Outcome of Mouse Vascularized Osteomyocutaneous Allotransplantation under Costimulation Blockade

C-.H. Lin,^1,2 M. Anggelia,^1,2 H. Yang,³ W. Chuang,⁴ H. Cheng,¹ F-.C. Wei,^1,2 G. Brandacher.⁵
Low Intensity Conditioning Protocol for Inducing Chimerism-Based Tolerance in Non-Obese Diabetic Mice

A. Chhabra, Y. Huang, H. Xu, A. Merchak, S. Ildstad.
Low Kidney Supply to Demand Ratio and Multi-Organ Transplant Centers Are Negatively Associated with Pediatric Renal Transplant Rates Post Kidney Allocation System Implementation: An Analysis of OPTN Data

P. Almond,¹ S. Al-Akash,¹ D. Stewart,² A. Robinson.²
Low Serum 3-Methyl Histidine Level is Associated with Peripheral Arterial Stiffness in Renal Transplant Recipients

B-.G. Hsu,^1,4 Y-.H. Lai,¹ J. Hou,¹ C-.H. Liu,³ M-.C. Lee.^2,4
Lower Incidence of De Novo Donor-Specific Antibodies against HLA-DR in ABO-Incompatible Renal Transplantation

M. Okada,¹ K. Futamura,¹ T. Hiramitsu,¹ M. Tsujita,¹ N. Goto,¹ S. Narumi,¹ Y. Watarai,¹ K. Iwasaki,² T. Kobayashi.²
Lower Uric Acid Level after Kidney Transplantation Impact on Better Long-Term Allograft Outcomes

D. Kim,¹ H. Choi,² Y. Jung,¹ J. Lee,¹ J. Lee,¹ J. Lee,¹ K. Huh,¹ M. Kim,¹ B. Kim,² Y. Kim.¹
Lymph Node Reprogramming: Microparticle Delivery of Immune Signals to Induce Tolerance and Prolong Allograft Survival

Y. Xiong,¹ L. Tostanoski,² C. Jewell,² J. Bromberg.¹
Lymph Node Stromal Laminins Affect Graft Survival through Regulation of CD4 T Cell Proliferation and Migration

L. Li, T. Simon, W. Piao, Y. Xiong, V. Saxena, T. Zhang, C. Wagner, J. Bromberg.
Lymph Node Stromal Laminins Modulate the Dynamic Balance of the Treg/Th17 Axis

L. Li, T. Simon, W. Piao, Y. Xiong, V. Saxena, T. Zhang, C. Wagner, J. Bromberg.
Lymphatic Endothelium Requires S1PR2 for T Cell Transendothelial Migration

Y. Xiong,¹ W. Piao,¹ C. Brinkman,¹ L. Li,¹ J. Kulinski,² A. Olivera,² A. Cartier,³ T. Hla,³ S. Schwab,⁴ K. Hippen,⁵ B. Blazar,⁵ J. Bromberg.¹
Lymphocyte Proportions Post Thymectomy Are Associated with Allergic Disorders in Heart Transplanted Children

T. Kim,¹ L. Ionescu,^1,2,3 N. Avdimiretz,⁴ M. Larsen,^1,2,3 F. Murdoch,^1,2 B. Motyka,^1,2,3 S. Gilmour,^1,2 L. West,^1,2,3 S. Urschel.^1,2,3
Lymphotoxin Beta Receptor Modulation in Lymphatic Endothelial Cells Alters Regulatory T Cell Dynamics

V. Saxena, W. Piao, Y. Xiong, L. Li, C. Wagner, J. Bromberg.

Jump to: View All • a b c d e f g h i j k [l] m n o p q r s t u v w x y z